Clinical Trial Update: A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating EpCAM-targeted CAR T cells across multiple cancers, including colon, esophageal, pancreatic, prostate, gastric, and he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• EpCAM-targeted CAR T cells (CAR T cell therapy targeting EpCAM)

Snippet

Sponsor: First Affiliated Hospital of Chengdu Medical College | Conditions: Colon Cancer, Esophageal Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN